このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Hims & Hers Health マネジメント
マネジメント 基準チェック /14
Hims & Hers Health'sの CEO はAndrew Dudumで、 Jan2017年に任命され、 の在任期間は 7.42年です。 の年間総報酬は$ 14.40Mで、 4.2%給与と95.8%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の9.07%を直接所有しており、その価値は$ 462.52M 。経営陣と取締役会の平均在任期間はそれぞれ2.3年と2.5年です。
主要情報
Andrew Dudum
最高経営責任者
US$14.4m
報酬総額
| CEO給与比率 | 4.2% |
| CEO在任期間 | 7.4yrs |
| CEOの所有権 | 9.1% |
| 経営陣の平均在職期間 | 2.3yrs |
| 取締役会の平均在任期間 | 2.5yrs |
経営陣の近況
Recent updates
Hims & Hers: The Undervalued Gem Poised For Growth
Jun 18Beyond The Marketing Machine: Why Hims & Hers Stock Might Be Vulnerable
Jun 10Hims & Hers Health, Inc.'s (NYSE:HIMS) CEO Compensation Is Looking A Bit Stretched At The Moment
May 31
Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead
May 21Hims & Hers Health: An Unforced Error
May 06Hims & Hers Health, Inc. (NYSE:HIMS) Stocks Pounded By 27% But Not Lagging Industry On Growth Or Pricing
May 04Hims & Hers Health: Becoming A Market Leader Within The Growing Digital Health Industry
Apr 24Hims & Hers Health: Strong Prospects But Weak Business Model Consolidation
Apr 05Hims & Hers: 5 Reasons Why This Is A Phenomenal Long-Term Growth Stock
Mar 21Pills Pay The Bills: Mini Deep Dive On Hims & Hers Health
Mar 12Investors Appear Satisfied With Hims & Hers Health, Inc.'s (NYSE:HIMS) Prospects As Shares Rocket 49%
Feb 28Hims & Hers: Turning The Profitability Corner And Returning 28%
Feb 25Hims & Hers Health: No Clear Moat Besides First Mover Advantage
Jan 23Hims & Hers Health: Unleashing Macro Momentum - Investing In Growth At A Higher Multiple
Jan 10Investors Still Waiting For A Pull Back In Hims & Hers Health, Inc. (NYSE:HIMS)
Jan 07Hims & Hers Health Q3: The Cheapest Growth Stock Around
Dec 14Hims & Hers Health: What Would The Author Of 100 Baggers Say?
Nov 30Hims & Hers: The Most Undervalued Small Cap Stock I See
Nov 08Hims & Hers: A Promising Company With Resolvable Challenges
Nov 02Hims & Hers: Specialization Is The Secret To Great Growth
Oct 25Hims & Hers Health: Can't Get Much Better
Sep 25The Market Is Wrong On Hims & Hers Health
Sep 18Hims & Hers: The Current Weakness Creates A Buying Opportunity
Aug 15Hims & Hers Health: Giving Investors Another Bite At The Apple
Aug 01Hims & Hers Health, Inc.'s (NYSE:HIMS) Price In Tune With Revenues
Jul 21Hims & Hers Health: Expect Strong EBITDA Growth As Revenue Growth Remains Strong
Jul 13Hims & Hers Health: Double-Edged Sword
Jul 02Hims & Hers: More Transparency Could Help The Stock
Jun 09Hims & Hers Health (NYSE:HIMS) Is In A Strong Position To Grow Its Business
Apr 19Are Investors Undervaluing Hims & Hers Health, Inc. (NYSE:HIMS) By 41%?
Mar 30Him & Hers Health Q4 2022 Earnings Preview
Feb 24Hims & Hers spikes as Jefferies upgrades ahead of 2023 guidance
Feb 09CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$2m |
| Dec 31 2023 | US$14m | US$612k | -US$24m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$47m |
| Mar 31 2023 | n/a | n/a | -US$59m |
| Dec 31 2022 | US$11m | US$600k | -US$66m |
| Sep 30 2022 | n/a | n/a | -US$86m |
| Jun 30 2022 | n/a | n/a | -US$83m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$15m | US$574k | -US$108m |
| Sep 30 2021 | n/a | n/a | -US$82m |
| Jun 30 2021 | n/a | n/a | -US$72m |
| Mar 31 2021 | n/a | n/a | -US$63m |
| Dec 31 2020 | US$27m | US$527k | -US$18m |
| Sep 30 2020 | n/a | n/a | -US$25m |
| Jun 30 2020 | n/a | n/a | -US$38m |
| Mar 31 2020 | n/a | n/a | -US$58m |
| Dec 31 2019 | US$254k | US$254k | -US$72m |
報酬と市場: Andrewの 総報酬 ($USD 14.40M ) は、 US市場 ($USD 8.45M ) の同規模の企業の平均を上回っています。
報酬と収益: Andrewの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Andrew Dudum (35 yo)
7.4yrs
在職期間
US$14,401,411
報酬
Mr. Andrew Dudum serves as Chairman of the Board and serves as Chief Executive Officer at Hims & Hers Health, Inc. since January 20, 2021. He Co-Founded Hims & Hers Health, Inc. in 2017. He is Co-founded H...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 7.4yrs | US$14.40m | 9.07% $ 462.5m | |
| Chief Financial Officer | 2.4yrs | US$7.43m | 0.068% $ 3.5m | |
| Chief Operating Officer | 3.4yrs | US$6.77m | 0.25% $ 12.9m | |
| Chief Legal Officer & Corporate Secretary | 3.4yrs | US$5.21m | 0.072% $ 3.7m | |
| Chief Medical Officer | 1.5yrs | US$198.26k | 0.090% $ 4.6m | |
| Chief Commercial Officer | less than a year | US$6.71m | 0.082% $ 4.2m | |
| Senior VP | 5yrs | US$961.12k | 0% $ 0 | |
| Chief Communications Officer | less than a year | データなし | データなし | |
| Senior Vice President of Human Resources | 2.3yrs | データなし | データなし | |
| Senior VP & Member of Medical Advisory Board | no data | データなし | データなし | |
| Chief Pharmacy & Innovation Officer | 1.5yrs | データなし | データなし | |
| Senior Vice President of Mental Health | 1.3yrs | データなし | データなし |
2.3yrs
平均在職期間
44yo
平均年齢
経験豊富な経営陣: HIMSの経営陣は 経験豊富 であると考えられます ( 2.3年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Co-Founder | 3.4yrs | US$14.40m | 9.07% $ 462.5m | |
| Chief Medical Officer | 2.3yrs | US$198.26k | 0.090% $ 4.6m | |
| Senior VP & Member of Medical Advisory Board | 2.4yrs | データなし | データなし | |
| Independent Director | 3.8yrs | US$194.26k | 0.025% $ 1.3m | |
| Lead Independent Director | 3.8yrs | US$227.41k | 0.082% $ 4.2m | |
| Independent Director | 3.3yrs | US$205.51k | 0.034% $ 1.7m | |
| Member of Medical Advisory Board | 2.5yrs | データなし | データなし | |
| Member of Medical Advisory Board | no data | データなし | データなし | |
| Member of Medical Advisory Board | 2.5yrs | データなし | データなし | |
| Member of Medical Advisory Board | 2.5yrs | データなし | データなし | |
| Member of Medical Advisory Board | 2.5yrs | データなし | データなし | |
| Member of Medical Advisory Board | 2.5yrs | データなし | データなし |
2.5yrs
平均在職期間
53yo
平均年齢
経験豊富なボード: HIMSの 取締役会 は 経験豊富 ではない ( 2.5年の平均在任期間) ため、新しい取締役会が必要であると考えられます。